New breakouts after starting sermorelin can reasonably make you wonder whether the medicine is involved. The timing is useful information, but it does not prove causation. Our review did not establish a reliable acne rate for current compounded sermorelin products or find a controlled study that could predict who will develop acne from them.
Tell the prescriber about a new or worsening skin problem, especially if other hormones or products changed around the same time. A clinician can assess whether the spots are acne, another skin condition, or an injection-related problem. Do not assume a rash is harmless “purging” or that worsening skin means the treatment is working.
New acne after starting treatment deserves a medication and skin-care review. Timing alone does not prove sermorelin caused it, and reliable product-specific acne rates were not established by this review.
Adult acne has more than one possible cause
The American Academy of Dermatology’s adult-acne guide explains that acne can continue or begin in adulthood, including later life. Hormonal changes, stress, medications, and skin-care products can contribute. A new prescription is one part of that history, not necessarily the complete explanation.
Write down when the skin change started, where it appears, and what else changed. Include new moisturizers, hair products, supplements, hormone treatments, and prescription changes. Photographs taken under similar lighting can help communicate a pattern to the clinician without becoming proof of its cause.
The skin and hair guide explains why broad claims about skin rejuvenation do not establish a particular benefit or side-effect rate for an individual preparation. Marketing language should not replace a diagnosis of the actual skin problem.
Check the entire hormone-treatment plan
Testosterone is a relevant example of another treatment that can contribute to acne. The AAD’s testosterone-therapy resource describes this relationship and explains that acne can be treated. That is evidence about testosterone therapy, not a study proving that sermorelin has the same effect.
If someone starts testosterone, sermorelin, and new supplements together, the sequence alone cannot identify which component matters. Give the clinician the complete list and the dates of changes. Our testosterone combination guide explains why each treatment needs a separate purpose and follow-up plan.
Do not stop a prescribed hormone regimen or add another hormone drug solely to manage an assumed mechanism. The prescriber and, when needed, a dermatologist can help distinguish a medication contribution from other causes and choose an appropriate response.
Acne is different from an injection-site reaction
A localized spot immediately around an injection, widespread itchy bumps, and persistent facial acne are different patterns. They should not all be labeled “sermorelin acne” without assessment. Note whether the problem occurs only at injection sites, follows each administration, or appears in areas unrelated to injections.
Our injection-site reaction guide covers irritation and symptoms that need medical attention. The purpose of recording the pattern is to help a professional assess it, not to diagnose a reaction from a photograph or internet description.
If symptoms are rapidly worsening or you feel seriously unwell, seek prompt medical advice rather than waiting for a routine skin-care visit. A product’s compounded status does not make unexpected symptoms less important or establish that the reaction is caused by the active ingredient alone.
Ask for treatment of the skin problem itself
Painful, persistent, or scarring acne deserves clinical assessment. The AAD advises discussing a suspected medication contribution with the clinician instead of making an unsupported assumption about what to stop. A dermatologist can also help when the diagnosis is uncertain or ordinary skin-care changes have not helped.
Avoid introducing several new acne products at once while also changing hormone treatment. That can make irritation and cause-and-effect harder to interpret. Bring the dispensing label and ingredient list so the clinician knows the exact preparation, including whether other active ingredients are present.
Decide what follow-up would clarify the question
Agree on how the skin problem will be documented, when it will be reviewed, and who will coordinate any prescription change. If the clinician changes one part of treatment, keep a record of the response. Improvement or recurrence can be informative, but it still needs clinical interpretation.
The general side-effect guide explains why patient reports and controlled evidence answer different questions. A useful plan takes the symptom seriously while avoiding an invented incidence rate, a guaranteed cause, or a promise that the breakout will disappear on a fixed timeline.
Sources & further reading
Provider pages describe offers; they do not independently establish treatment benefits. Sources checked September 20, 2026.
This article is education, not a diagnosis, prescription, or dosing plan. Discuss treatment and alternatives with a licensed clinician who knows your history. Compounded medications are not FDA-approved.